会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • System for Seeking for an Optimal Configuration of a Bi-, Tri- or Multi-ventricular Cardiac Resynchronization Implanted Device
    • 用于寻求双,三心室或多心室心脏再同步植入装置的最佳配置的系统
    • US20120226329A1
    • 2012-09-06
    • US13411412
    • 2012-03-02
    • Fabrizio RenestoLionel Giorgis
    • Fabrizio RenestoLionel Giorgis
    • A61N1/37
    • A61N1/36578A61N1/3627A61N1/3682A61N1/3684A61N1/3686A61N1/3706
    • An apparatus and a system for seeking for an optimal configuration of a bi-, tri- or multi-ventricular cardiac resynchronization implantable medical device. This system includes ventricular pacing, a signal representative of an endocardial acceleration (EA) of a patient's heart, and isolating and pre-processing the EA signal to obtain an EA1 component and an EA2 component. The effectiveness of the current pacing configuration is evaluated by one or more composite indexes that combine at least two of the following parameters: peak-to-peak amplitude (PEA1) of the EA1 component; time occurrence (TstEA1) of the beginning of the EA1 component; time interval (LargEA1) between the beginning of the EA1 component and the moment of the energy peak of the EA1 component; and duration of systole (Syst), represented by the time interval between the beginning (TstEA1) of the EA1 component and the beginning (TstEA2) of the EA2 component.
    • 用于寻求双心室,三心室或多心室再同步植入式医疗装置的最佳配置的装置和系统。 该系统包括心室起搏,代表患者心脏的心内加速度(EA)的信号,以及分离和预处理EA信号以获得EA1分量和EA2分量。 目前的起搏配置的有效性由一个或多个组合索引来评估,所述复合索引组合以下参数中的至少两个:EA1分量的峰 - 峰幅度(PEA1); 时间发生(TstEA1)开始的EA1组件; EA1分量开始时间间隔(LargEA1)与EA1分量能量峰值时刻间隔(LargEA1); 和持续时间(Syst),由EA1组分的起始点(TstEA1)与EA2组分的起始点(TstEA2)之间的时间间隔表示。
    • 2. 发明授权
    • System for seeking for an optimal configuration of a bi-, tri- or multi-ventricular cardiac resynchronization implanted device
    • 用于寻求双,三心室或多心室心脏再同步植入装置的最佳配置的系统
    • US08712526B2
    • 2014-04-29
    • US13411412
    • 2012-03-02
    • Fabrizio RenestoLionel Giorgis
    • Fabrizio RenestoLionel Giorgis
    • A61N1/00
    • A61N1/36578A61N1/3627A61N1/3682A61N1/3684A61N1/3686A61N1/3706
    • An apparatus and a system for seeking for an optimal configuration of a bi-, tri- or multi-ventricular cardiac resynchronization implantable medical device. This system includes ventricular pacing, a signal representative of an endocardial acceleration (EA) of a patient's heart, and isolating and pre-processing the EA signal to obtain an EA1 component and an EA2 component. The effectiveness of the current pacing configuration is evaluated by one or more composite indexes that combine at least two of the following parameters: peak-to-peak amplitude (PEA1) of the EA1 component; time occurrence (TstEA1) of the beginning of the EA1 component; time interval (LargEA1) between the beginning of the EA1 component and the moment of the energy peak of the EA1 component; and duration of systole (Syst), represented by the time interval between the beginning (TstEA1) of the EA1 component and the beginning (TstEA2) of the EA2 component.
    • 用于寻求双心室,三心室或多心室再同步植入式医疗装置的最佳配置的装置和系统。 该系统包括心室起搏,代表患者心脏的心内加速度(EA)的信号,以及分离和预处理EA信号以获得EA1分量和EA2分量。 目前的起搏配置的有效性由一个或多个组合索引来评估,所述复合索引组合以下参数中的至少两个:EA1分量的峰 - 峰幅度(PEA1); 时间发生(TstEA1)开始的EA1组件; EA1分量开始时间间隔(LargEA1)与EA1分量能量峰值时刻间隔(LargEA1); 和持续时间(Syst),由EA1组分的起始点(TstEA1)与EA2组分的起始点(TstEA2)之间的时间间隔表示。
    • 3. 发明授权
    • Device for characterizing the cardiac status of a patient equipped with a biventricular pacing active implant
    • 用于表征装备有双心室起搏活性植入物的患者的心脏状态的装置
    • US08874209B2
    • 2014-10-28
    • US12331286
    • 2008-12-09
    • Fabrizio RenestoFilippo Ziglio
    • Fabrizio RenestoFilippo Ziglio
    • A61N1/00A61N1/362A61N1/365A61N1/368
    • A61N1/3627A61N1/36542A61N1/36578A61N1/3682A61N1/3684
    • A medical device for characterizing the cardiac status of a patient equipped with a bi-ventricular pacing active implant device. The implant collects an endocardiac acceleration signal and searches for an optimal pacing configuration. This latter tests a plurality of different pacing configurations and delivers for each tested configuration parameters derived from the endocardiac acceleration peak (PEA). The device derives a patient clinical status from those parameters, the indication being representative of the patient's response to the cardiac resynchronization therapy. Those parameters include: the possibility to automatically get or not a valid optimal AV Delay among all the biventricular pacing configurations; a factor indicating the character sigmoid of the PEA/AVD characteristic; the average value of the PEA for the various configurations; and the PEA signal/noise ratio. The active implantable medical device includes control software and processes for executing the characterizing functionality described.
    • 用于表征装备有双心室起搏活动植入装置的患者的心脏状态的医疗装置。 植入物收集心内加速度信号并搜索最佳的起搏配置。 后者测试多个不同的起搏配置,并为从心内膜加速峰(PEA)得到的每个测试配置参数递送。 该装置从这些参数中导出患者临床状态,该指征代表患者对心脏再同步治疗的反应。 这些参数包括:在所有双心室起搏配置中自动获得有效的最佳AV延迟的可能性; 表示PEA / AVD特征的字符Sig的一个因子; 各种配置的PEA的平均值; 和PEA信号/噪声比。 主动植入式医疗装置包括用于执行描述的特征功能的控制软件和处理。
    • 5. 发明授权
    • Active implantable medical device for cardiac resynchronization with automatic optimization of atrioventricular and interventricular delays
    • 用于心脏再同步的主动植入式医疗装置,具有房室和室间延迟的自动优化
    • US08219193B2
    • 2012-07-10
    • US12906844
    • 2010-10-18
    • Fabrizio RenestoCyrille Casset
    • Fabrizio RenestoCyrille Casset
    • A61N1/368
    • A61N1/368A61B5/0468A61B5/1107A61B5/6869A61N1/36578A61N1/3682A61N1/3684A61N1/37264
    • An active implantable medical device for cardiac resynchronization with automatic optimization of atrioventricular and interventricular delays is disclosed. The device collects an endocardial acceleration signal EA and calculates the atrioventricular delay AVD and the interventricular delay VVD. The device isolate in the EA signal a component EA4 corresponding to the fourth EA peak and measure a temporal parameter related to a time interval between the detection of an atrial event (P/A) and the occurrence of the EA4 component. The device isolates an EA1 component corresponding to the first EA peak and measures a non-temporal parameter (APEA1) related to the peak amplitude or a signal energy of the EA1 component. The optimal AVD (AVDO) is determined by the temporal parameter related to the EA4 component, and is calculated for a plurality of different values of VVD to obtain a plurality of pairs of optimal values {AVDO, VVD}. The device selects one of these pairs of values based on the non-temporal parameter related to the EA1 component.
    • 公开了一种用于心脏再同步的主动植入式医疗装置,其具有房室和室间延迟的自动优化。 该装置收集心内加速度信号EA并计算房室延迟AVD和室间延迟VVD。 EA中的器件分离出与第四EA峰对应的分量EA4,并测量与心房事件(P / A)的检测与EA4分量的发生之间的时间间隔相关的时间参数。 该装置隔离对应于第一EA峰值的EA1分量,并测量与峰值振幅或EA1分量的信号能量相关的非时间参数(APEA1)。 通过与EA4分量相关的时间参数确定最佳AVD(AVDO),并且针对多个不同的VVD值计算以获得多对最优值{AVDO,VVD}。 该设备基于与EA1组件相关的非时间参数来选择这些值对之一。